Shield Therapeutics Share Discussion Threads

[innittowinit] 10/12/2020 10:51

What director sale?

[frrinvest] 10/12/2020 10:47

Never was impressed with Tim, said it all along. In hindsight the Director sale was a give away so close to the pending announcement. Must be ripe for a takeover now at a giveaway price.

[shandypants2] 10/12/2020 10:41

clearly this is very disappointing. STX had one strategic objective this year, an US deal, and they have failed to deliver.
Tim as CEO has lost all credibility now and so can't see him staying beyond his 1 year contract that ends in April 2021. To give such a positive update in September, when issues must already have been known, is poor.
STX clearly wanted a single deal (probably as large US pharmas wanted this arrangement) but it appears the 1 or 2 preferred parties had issues so these deals didn't get concluded.
Now it looks like STX may undertake a number of smaller deals based on specific therapeutics and/or launch themselves. Whilst there are attractions for the latter as STX has minimal staff, non of whom have sales experience, and limited cash this seems quite a bold move. Potentially it will strength negotiations as they at least have an alternative option, unlike today.
Have to say a low ball offer may be the best option all round ATM. Which companies control the IV market? Seems an obvious link up. I'd take 150p

[innittowinit] 10/12/2020 10:37

Well that's all a bit of a bumer eh!!

A few thoughts:

(New) strategy - from the RNS "...in order to maximise the Group’s options, in parallel with continuing ongoing discussions with potential licence partners it should explore the potential launch of Accrufer® in the US by Shield, possibly including co-promote and/or sub-licence partners in specific therapeutic areas. To this end, work is being carried out with US-based consultants and other advisers to develop a strategy and plans for a Shield-led launch."

Sounds like they have had licensing offers from a bunch of smaller companies, none of which is attractive enough on its own, but collectively (with co-ordination) it could be an attractive option. The cash needs they are talking about support this premise as $30-40m is nowhere near enough to launch successfully in the USA.

Debt provision - as the 1st drawn down isn't until Feb and the company isn't bound by it unlike the 2 providers, reading between the lines perhaps they still think they can get a deal done and not need to draw on it. Here's hoping...

NEDs etc... realy need to put their money where their collective mouths are and invest in the company. Llewelyn Davies, HAsler and Hoffman have behaved appallingly and are a disgrace so it is high time that changed Schweiger is little different as his shares come from being a 'co-founder' as he is so keen to state. He sold >1m shares last year according to the stated shareholdings. Even the CEO should do something although at least he has paid the tax on c. 400k share options he exercised.

Presumably they are all out of any closed period now with this cleansing statement so they should all stop hiding behind such things and step up.

Also disappointing that the did not use the RNS to update on China and Europe and H2H publication... Presumably Peel Hunt as NOMAD took the red pen to anything positive!!

Amazing that a prodduct with the potential this has is seemingly proving to be so difficult to do a deal on, so what on earth are the terms the largest shareholders are wanting as they are the real decision makers here. I guess the former CEO got sick of such issues in the end, as after all he got the Europe and China deals done and of course raised all the money the company has had access to. They should bring him back... oh but no they can't as he's taken another role!!

Muppetts!

[powerp2] 10/12/2020 10:26

I now dream of £1.75 which is about the price i paid for my shares.
Who wrote that song " what kind of fool am I"

[lovewinshatelosses] 10/12/2020 10:09

I would take 150p, but I have an average of 118p, so easy for me to say, I guess.
Really regretting my averaging up purchases now though!
Whatever the outcome, I just really hope the major holders do not let the management get away with any more failures. Frankly, I would like to see them apply serious pressure to have them make some notable purchases from their own pockets.
If they do not, get rid. Too many senior managers riding the gravy trains on AIM, IMO.

[nobbygnome] 10/12/2020 09:56

I agree with all the posts about the poor management performance here. I gave them the benefit of the doubt but have been proved wrong. But a market cap of less than £100 million when they have an approved drug for a large potential market, which is already selling in some is clearly ridiculous.

As has been said they must be a sitting duck now. I reckon a cheeky bid of say £1.75 would probably secure enough acceptances. Complete madness but it could well happen now.

[onceaday] 10/12/2020 09:43

If the market has changed and there is no longer a need for a large sales force in the US then the same should be true of Europe. If they roll out the "COVID stopping sales reps visiting doctors" excuse again to explain poor sales in Europe then reach your own conclusion.

Carl obviously had some idea things were going pear shaped.

[lako42] 10/12/2020 09:31

Well it isn't Peachie, so probably best to move on with that one.

Maybe the worlds biggest supplier of IV will have a look.......

[peachie 74] 10/12/2020 09:22

Not what was wanted particularly.
BUT this still is a fantastic product for a huge market. That hasn’t changed.

I cannot believe this isn’t on a big Pharma’s radar. We will see

[lovewinshatelosses] 10/12/2020 09:20

Given how little progress this company seems to have made for a long time now, would it really be taken out for the current market cap, let alone more?
I guess if we see some TR1's with existing holders adding shortly (or in the land of fantasy, BOD buys), then maybe that will be enough to limit the bleeding somewhat, but I have real concerns now. Re-reading that RNS just confirms the initial criticisms of the state of play that most of us seem to have here.
I either need to add or sell, but as my recent purchase has proven, maybe I should do the opposite to what I intend to, at the point of hitting the buy or sell button! Might make the right decision then.
FWIW, I would be delighted to see a take over now and would happily take a smaller number than the broker targets. The next three months are going to be absolutely crucial to this company and for us holders, IMO.

[greyarea10] 10/12/2020 09:14

You can view the boards without being registered you know.

[best1467] 10/12/2020 08:51

On the basis they failed gain any sales in Europe going it alone making a success of it in States is unlikely

[diversification] 10/12/2020 08:51

They are now a sitting duck for a takeover, the market leader must be rubbing their hands together!

[powerp2] 10/12/2020 08:49

Was TEVAs withdrawal actually a reflection of their view of the opportunity?
Sadly Tim Watts' credibility is now zero and frankly I don't trust him anymore.

[stalker_boy] 10/12/2020 08:47

Really GreyArea

GreyArea10
Member since: 10 Dec 2020

You have been a lurker for a bloody long time

[ny boy] 10/12/2020 08:45

Yes a bit frustrating for long term holders, seems ages ago when I started buying these sub 40p and again on the big pull back, anyway done very well on sticks generally since March, so decided to add on this dip, surprised it was difficult to buy stock, any done, let’s hope for a much better 2021 Will check back in on progress during the Spring.

[greyarea10] 10/12/2020 08:42

I'm a lurker on these boards and have never felt the need to post before but the board of this company are utterly incompetent in communicating to the market. If they are still in discussions then say that, don't make the main point of the RNS be your failure to deliver or, and here's the big brain move, shutup until you actually know the answer, if you don't know the answer then you don't have to communicate anything. Knowing something can be a very subjective.

The only other thing I can imagine is that they DO know the answer, there is no licensing deal.

[its the oxman] 10/12/2020 08:34

Short term hit but great time to add. Still significant value here.

[lako42] 10/12/2020 08:32

What a surprise. Looks like I'm kicking myself again today. A bunch of amateurs at the wheel. I have to wonder what they have been doing on a daily basis to earn those horid salaries and bonuses...... Not enough.

I'm the biggest fool on here as I've been calling it.

[1gw] 10/12/2020 08:27

weatherman - I suspect going it alone in the US is not often a recipe for success for UK companies. It takes deep pockets and good local knowledge. Maybe this time it will be different, but with the track record of this executive team? I think a more likely route to salvation for shareholders is that one of the potential licensees/partners believes STX's threat to go it alone is credible and so stops messing around and offers deal terms that STX feel they can accept.

[ramnik007] 10/12/2020 08:19

About a month ago I posted 'what does the regular seller know that we don't', given the US newsflow expected'. I guess today's news is what they knew about and had started off loading at 125p level all the way to 105p. My conspiracy theory!

[weatherman] 10/12/2020 08:18

Oh well - if they go it alone in US, they will have bigger margins in the long run.

[1gw] 10/12/2020 08:13

They seem to have forgotten to put in something about publication of the clinical study report as well. If my notes from an earlier proactive interview are correct, they were expecting that back in September/October.

It does all make the executive team look like amateurs, doesn't it? What chance a more professional and better-financed company might be willing to put them out of their misery with an acquisition offer?

[lovewinshatelosses] 10/12/2020 08:02

I missed the bit stating how many shares Tim was going to buy for himself. Sarcasm aside, am very unimpressed with him to be honest. Hard not to be, really. I think we all feared this might have been the issue as those deadlines kept slipping. It makes my recent top up all the more brainless.
Peel Hunt can have my shares for 150p, seeing as they think so much value remains here :)